Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 279.60 Billion | USD 703.70 Billion | 10.8% | 2023 |
Zion Market Research has published a report on the global Automation and Control System Market, estimating its value at USD 279.60 Billion in 2023, with projections indicating that it will reach USD 703.70 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 10.8% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Automation and Control System Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
The global Automation and Control System Market in Pharmaceutical and Biotech Industry accounted for USD 22.2 Billion in 2020 and is expected to reach USD 37.9 Billion by 2028, growing at a CAGR of around 6.8% between 2021 and 2028.
Automation basically means the use of various control systems for operating equipment like machinery, processes in factories, boilers and heat treating ovens, stabilization of ships, aircrafts and other applications and vehicles with minimal or reduced human intervention. Automation and control system is the integration of IT technology with the mechanical systems. These systems are used for reliable and standardized production systems. It offers customers improved quality with standardization and dependable products within the time and at an economical cost. In the pharmaceutical and biotech industry automation and control systems are mainly used for manufacturing and packaging, to provide high quality products and also improving efficiency in manufacturing and packaging.
Various industries has been impacted due to rapid spreading COVID19 on each stage of its value chain through mediums of affected workforce at industrial level, raw material supply, trade & logistics, demand–supply volatility, and uncertain consumer demand at retail outlets. Due to high wages and workforce shortages, the developed countries are investing exponentially in automation and control. Trade restrictions imposed by several countries across the globe to prevent further spread of coronavirus has significantly affected global logistics and transportation, which, in turn, has slightly impacted the Automation and Control System Market in Pharmaceutical and Biotech Industry.
Factors like the rise in generic drugs, increasing prevalence of chronic illness, growing need for productivity of pharmaceutical drugs and the rising investment by biotechnology market for new drugs are expected to escalate the need for automation and control systems thereby driving the market. Also the growing healthcare awareness and technological advancement is fueling the market significantly. Increasing R&D and the outsourcing of pharmaceutical companies is also leading the market growth in automation and control systems. However, the absence of skilled workers and the different standards adopted by the different equipment manufacturers are some major factors hampering the growth of this market.
Report Attributes | Report Details |
---|---|
Report Name | Automation and Control System Market |
Market Size in 2023 | USD 279.60 Billion |
Market Forecast in 2032 | USD 703.70 Billion |
Growth Rate | CAGR of 10.8% |
Number of Pages | 120 |
Key Companies Covered | General Electric, Honeywell International, Siemens AG, M+ W Group, Fanuc Corporation, Mitsubishi Electric Corporation, OMRON Corporation, ABB Group, Schlumberger Limited, Stratasys Ltd, among others |
Segments Covered | By Type, By Technology, By Application, By Approach and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Communication technology available in Automation and Control System Market in Pharmaceutical and Biotech Industry are wired technology and Wireless technology. Among them, the demand for Wired technology is relatively higher and the trend is anticipated to remain so over the next few years.
Based on offering, the market is segmented into facility management systems, fire protection systems and security and access control systems. Facility management systems segment held the major share in the Automation and Control System Market in Pharmaceutical and Biotech Industry. Manufacturing sector are preparing themselves for industry 5.0, Adaption of IOT, and artificial intelligence. This growing demand for automation & control due to the rise of industry 5.0 and its adaption across the industries is likely to spur the growth of the market.
North America is expected to dominate the market for automation and control systems in pharmaceutical and biotech industry, owing to the huge number of ageing population and the growing investments in the industry. Technological advancement along with the trend of awareness about the industry has led to the growth of the market in this region. APAC followed by Europe is estimated to be the fastest growing regions in the automation and control systems market. Emerging economies like India and China are growing rapidly due to the increasing investments in R&D, large pool of patients and the growing government funding with the rising awareness about healthcare sector. Also the growing trend in technological advancements is expected to fuel the market in these regions.
Major players in the Automation and Control System Market in Pharmaceutical and Biotech Industry are General Electric, Honeywell International, Siemens AG, M+ W Group, Fanuc Corporation, Mitsubishi Electric Corporation, OMRON Corporation, ABB Group, Schlumberger Limited, Stratasys Ltd, among others.
By Type
By Technilogy
By Application
By Approach
By Region
FrequentlyAsked Questions
The global Automation and Control System Market in Pharmaceutical and Biotech Industry was valued at USD 22.2 billion in 2020.
The global Automation and Control System Market in Pharmaceutical and Biotech Industry is expected to reach USD 37.9 billion by 2028, growing at a CAGR of 6.8% between 2021 to 2028.
Some of the key factors driving the global Automation and Control System Market in Pharmaceutical and Biotech Industry growth are rise in generic drugs, increasing prevalence of chronic illness, growing need for productivity of pharmaceutical drugs and the rising investment by biotechnology market for new drugs.
North America is expected to dominate the market for automation and control systems in pharmaceutical and biotech industry, owing to the huge number of ageing population and the growing investments in the industry. Technological advancement along with the trend of awareness about the industry has led to the growth of the market in this region.
Major players in the Automation and Control System Market in Pharmaceutical and Biotech Industry are General Electric, Honeywell International, Siemens AG, M+ W Group, Fanuc Corporation (Japan), Mitsubishi Electric Corporation (Japan), OMRON Corporation (Japan), ABB Group (Switzerland), Schlumberger Limited, Stratasys Ltd, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed